Lapatinib and gemcitabine for metastatic pancreatic cancer: A phase II study

被引：0
|
作者：
Safran, H.
Miner, T.
Bahary, N.
Whiting, S.
Lopez, C.
Sun, W.
Charpentier, K.
Charpentier, K.
Shipley, J.
Anderson, E.
McNulty, B.
机构：
[1] Brown Univ, Oncol Grp, Providence, RI 02912 USA
[2] Univ Pittsburgh, Med Ctr, Pittsburgh, PA USA
[3] Fred Hutchinson Canc Res Ctr, Seattle, WA 98104 USA
[4] Oregon Hlth & Sci Univ, Portland, OR 97201 USA
[5] Univ Penn, Ctr Canc, Philadelphia, PA 19104 USA
[6] Brown Univ, Rhode Isl Hosp, Providence, RI 02903 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2009年 / 27卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e15653
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Lapatinib and Gemcitabine for Metastatic Pancreatic Cancer A Phase II Study
    Safran, Howard
    Miner, Thomas
    Bahary, Nathan
    Whiting, Sam
    Lopez, Charles D.
    Sun, Weijing
    Charpentier, Kevin
    Shipley, Joshua
    Anderson, Elliot
    McNulty, Brendan
    Schumacher, Andrew
    Clark, Alessandra
    Vakharia, Jamsheed
    Kennedy, Teresa
    Sio, Terence
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2011, 34 (01): : 50 - 52
  • [2] Phase II study of lapatinib and capecitabine in second-line treatment for metastatic pancreatic cancer
    Zheng Wu
    Andrew Gabrielson
    Jimmy J. Hwang
    Michael J. Pishvaian
    Louis M. Weiner
    Tingting Zhuang
    Lisa Ley
    John L. Marshall
    Aiwu Ruth He
    Cancer Chemotherapy and Pharmacology, 2015, 76 : 1309 - 1314
  • [3] A phase II study of lapatinib and capecitabine in second-line treatment of metastatic pancreatic cancer
    Wu, Zheng
    Marshall, John
    Hwang, Jimmy J.
    Pishvaian, Michael J.
    Wellstein, Anton
    Weiner, Louis M.
    He, Aiwu Ruth
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [4] Phase II study of lapatinib and capecitabine in second-line treatment for metastatic pancreatic cancer
    Wu, Zheng
    Gabrielson, Andrew
    Hwang, Jimmy J.
    Pishvaian, Michael J.
    Weiner, Louis M.
    Zhuang, Tingting
    Ley, Lisa
    Marshall, John L.
    He, Aiwu Ruth
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2015, 76 (06) : 1309 - 1314
  • [5] Phase II study of combination chemotherapy with gemcitabine and cisplatin for patients with metastatic pancreatic cancer
    Ueno, Hideki
    Okusaka, Takuji
    Ikeda, Masafumi
    Morizane, Chigusa
    Ogura, Takashi
    Hagihara, Atsushi
    Tanaka, Tsutomu
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2007, 37 (07) : 515 - 520
  • [6] Phase II study of gemcitabine combined with uracil-tegafur in metastatic pancreatic cancer
    Lee, J
    Park, JO
    Kim, WS
    Lee, SI
    Song, SY
    Lim, DH
    Choi, SH
    Heo, JS
    Lee, KT
    Lee, JK
    Heo, JS
    Kim, K
    Jung, CW
    Im, YH
    Lee, MH
    Kang, WK
    Park, K
    ONCOLOGY, 2004, 66 (01) : 32 - 37
  • [7] Lapatinib/gemcitabine and lapatinib/gemcitabine/oxaliplatin - A phase I study for advanced pancreaticobiliary cancer
    Safran, Howard
    Miner, Thomas
    Resnick, Murray
    Dipetrillo, Thomas
    McNulty, Brendan
    Evans, Devon
    Joseph, Plakyil
    Plette, Angela
    Millis, Robin
    Sears, Dina
    Gutman, Ned
    Kennedy, Teresa
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2008, 31 (02): : 140 - 144
  • [8] A phase II trial of gemcitabine and celecoxib for metastatic pancreatic cancer.
    Xiong, HQ
    Hess, KR
    Kayaleh, OR
    Goodwin, JW
    Banerjee, T
    Sinclair, SS
    Fisch, MJ
    Wolff, RA
    Abbruzzese, JL
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 351S - 351S
  • [9] Gemcitabine, oxaliplatin, and capecitabine (GEMOXEL) compared with gemcitabine alone in metastatic pancreatic cancer: a randomized phase II study
    Roberto Petrioli
    Giandomenico Roviello
    Anna Ida Fiaschi
    Letizia Laera
    Daniele Marrelli
    Franco Roviello
    Edoardo Francini
    Cancer Chemotherapy and Pharmacology, 2015, 75 : 683 - 690
  • [10] Gemcitabine, oxaliplatin, and capecitabine (GEMOXEL) compared with gemcitabine alone in metastatic pancreatic cancer: a randomized phase II study
    Petrioli, Roberto
    Roviello, Giandomenico
    Fiaschi, Anna Ida
    Laera, Letizia
    Marrelli, Daniele
    Roviello, Franco
    Francini, Edoardo
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2015, 75 (04) : 683 - 690
12345